Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Late gains lift Footsie

Mon, 29th Jun 2009 16:50

After a rather sluggish start to the day, Footsie ended with chunky gains, helped by buoyancy on Wall Street. Lloyds Banking topped the list of risers after Goldman Sachs raised its rating on the shares from "neutral" to "buy" and added them to its "conviction buy" list. Goldman Sachs has also lifted its target price from 61p to 107p, after arguing that the market has overdone the doom and gloom for the sector. Barclays, for which Goldman's has a "neutral" rating, and Royal Bank of Scotland, move higher, holding on to Lloyds' coat-tails.Broker coverage also boosted oil firm BG Group, which had its 'outperform' rating re-iterated at Cazenove.And car insurer Admiral was wanted after Credit Suisse upgraded its rating on the stock from "neutral" to "outperform", with an unchanged price target of 1097p.Elsewhere in the financial sector, the generally upward trend of European stock markets today gives a lift to insurers such as Legal & General, Old Mutual and Prudential. Inter-dealer brokers ICAP and Tullett Prebon also get a boost from renewed market optimism. Miners were weak, however, with bid stock Anglo American shifting into reverse before recovering later. Potential merger partner Xstrata ended lower.Outsource giant Serco climbs after it said it remains on track to deliver on its 2009 guidance and continues to see significant opportunities in the current challenging economic environment. Aero-engine developer Rolls-Royce has bought a 33% holding in ODIM, a provider of specialist marine handling systems to the offshore oil and gas industry. Rolls-Royce is paying NOK 700 (£66m) cash to Aker Solutions for 15.5m ordinary shares in ODIM, equivalent to NOK 45 per share.Vodafone edges higher after reports it is poised to buy the T-Mobile business in the UK if it can get it past the regulatory authorities. National Express is another on the up after confirming this morning it has received a bid from rival FirstGroup, which slips back. Hovis to Branston Pickle maker Premier Foods's trading this year has continued on track, with sales of bread especially described as excellent. The heavily indebted group, which raised £379m through a cash call in March, said sales in May and June were in line with the trends in the first four months of 2009. Informa warned that half-year organic revenues at its Events and Training unit will be 'considerably' lower as the group continued to reduce volume to protect profitability in the face of weak demand. Despite this, the high variable cost base will mean that the impact on adjusted operating profit margin will be limited. The share is the best performer among FTSE 350 constituents after Royal Bank of Scotland issued a "buy" recommendation.The stock market recovery since March has boosted the fourth quarter performance of investment management firm Hargreaves Lansdown, which now expects full-year results to be ahead of market expectations. Sector peer Brewin Dolphin moves up in sympathy.Defence group Cobham has landed a big contract to provide communication systems to the US Army. A Cobham-Northrop Grumman team (NGCI) has been selected to provide the VIS-X Vehicular Intercommunication System Expanded for the US Army's Communications and Electronics Command (CECOM). Online fashion retailer Asos produced another year of eye-popping growth, with sales doubling and profits up 93%, though it cautioned its rate of growth could be starting to slow.Sofa and mattress maker Airsprung Furniture is sitting pretty after it returned to profit in the second half of its financial year despite revenues showing little sign of recovery. Titan Europe, which designs and makes undercarriage components for industrial vehicles, said its markets have weakened some more in the second quarter of the company's financial year. The company, which expects to make a loss at the interim stage, said revenue for the first half of 2009 is expected to be around 35% lower than the first half of 2008.Drug developer Alizyme said it is likely to cut a 'significant' number of jobs and may even face going bust if it fails to secure sufficient funding. The group said it does not now expect to have sufficient funding to last beyond the end of August and will be unable to continue as a going concern without the raising of additional funds.Swiss drugs giant Novartis has started a Phase III clinical study of NVA, the treatment it licensed from joint-developers Vectura Group and Sosei Group, triggering milestone payments for both companies.Automated warehousing systems firm SDI is feeling optimistic on the back of an increasing number of contract wins, despite tumbling into the red.FTSE 100 - RisersLloyds Banking Group (LLOY) 70.56p +6.12%Prudential (PRU) 422.75p +5.89%Rio Tinto (RIO) 2,153.00p +4.51%Barclays (BARC) 279.65p +4.31%BG Group (BG.) 1,037.00p +4.12%Schroders (SDR) 846.50p +3.67%Rolls-Royce Group (RR.) 365.75p +3.61%Man Group (EMG) 286.00p +3.53%Old Mutual (OML) 80.69p +3.45%Aviva (AV.) 341.50p +3.41%FTSE 100 - Fallers3i Group (III) 237.50p -2.06%Xstrata (XTA) 672.10p -2.03%Thomas Cook Group (TCG) 199.90p -1.89%British Airways (BAY) 127.50p -1.39%GlaxoSmithKline (GSK) 1,067.50p -1.07%Associated British Foods (ABF) 762.00p -0.91%TUI Travel (TT.) 232.25p -0.85%Marks & Spencer Group (MKS) 309.50p -0.80%Balfour Beatty (BBY) 309.50p -0.64%Pearson (PSON) 605.50p -0.57%FTSE 250 - RisersNational Express Group (NEX) 302.75p +9.79%Informa (INF) 231.00p +9.09%Tullett Prebon (TLPR) 293.25p +8.61%Vectura Group (VEC) 70.50p +8.46%Dunelm (DNLM) 219.50p +6.42%Restaurant Group (RTN) 151.75p +6.30%Morgan Crucible (MGCR) 99.00p +6.17%Brewin Dolphin (BRW) 135.00p +5.88%Moneysupermarket.com (MONY) 51.25p +5.67%Electra Private Equity (ELTA) 945.00p +5.47%FTSE 250 - FallersSThree (STHR) 179.75p -4.77%Punch Taverns (PUB) 105.50p -4.31%DS Smith (SMDS) 67.50p -3.57%Marston's (MARS) 115.25p -2.74%Evolution Group (EVG) 145.00p -2.68%Peter Hambro Mining (POG) 620.00p -2.67%Berkeley Group Holdings Units (BKG) 798.00p -2.27%Northern Foods (NFDS) 54.25p -2.25%Renishaw (RSW) 342.00p -2.15%Ferrexpo (FXPO) 139.00p -2.11%
More News
19 Apr 2018 12:53

hVIVO CEO Steps Down In Favour Of Executive Chair As Loss Narrows

LONDON (Alliance News) - Clinical development and drug discovery business hVIVO PLC said Thursday its loss narrowed in 2017 as Chief Executive Kym Denny stepped aside for Executive Chairman Trevor

Read more
3 Apr 2018 08:41

EUROPE RESEARCH ROUNDUP-Aevis Victoria, Martela Oyj, Mediaset

April 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Aevis Victoria, Martela Oyj and Mediaset, on Tuesday. HIGHLIGHTS * Aevis SA

Read more
23 Mar 2018 18:23

DIRECTOR DEALINGS: Vectura Non-Executive Juliet Thompson Buys Shares

LONDON (Alliance News) - Vectura Group PLC said Friday Non-Executive Director Juliet Thompson bought shares worth GBP36,284 in the pharmaceutical company after

Read more
22 Mar 2018 16:16

DIRECTOR DEALINGS: Vectura Chairman, Non-Exec Director Buy Shares

LONDON (Alliance News) - Vectura Group PLC said on Thursday that two directors bought shares in the company on Wednesday.Chairman Bruno Angelici purchased 75,000 shares

Read more
21 Mar 2018 08:52

Vectura Delivers "Good" 2017 Results Despite Advair Disappointment

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC said Wednesday it delivered a "good" set of 2017 results with underlying profit and revenue growth to

Read more
21 Mar 2018 08:31

UPDATE 1-UK's Vectura posts wider 2017 loss, revenue rise

March 21 (Reuters) - British drugmaker Vectura reported a worse-than-expected pretax loss for the full year on Wednesday, dragged by lower royalties and higher costs related to the SkyePharma for

Read more
21 Mar 2018 07:47

UPDATE 1-UK Stocks-Factors to watch on March 21

March 21 (Reuters) - Britain's FTSE 100 index is seen opening up 13 points on Wednesday, according to financial bookmakers, with futures 0.26 pct higher ahead of the cash

Read more
21 Mar 2018 07:40

Drugmaker Vectura's 2017 revenue rises 17.2 pct

March 21 (Reuters) - British drugmaker Vectura reported a 17.2 percent rise in 2017 revenue on Wednesday, aided by higher demand for its asthma products Flutiform and Ultibro. The company,

Read more
20 Mar 2018 13:21

Legal & General Increases Vectura Stake To 3.7% From Below 3% (ALLISS)

LONDON (Alliance News) - Vectura Group PLC said Tuesday FTSE 100-listed insurer and asset manager Legal & General Group PLC increased its stake in the pharmaceutical firm

Read more
14 Mar 2018 16:20

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 15 March Old MutualFull Year ResultsPhoenix GroupFull Year GroupFull 16

Read more
12 Mar 2018 10:43

WINNERS & LOSERS SUMMARY: Vectura And Hikma Hurt By US FDA Ruling

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------easyJet, up 2.3% at on

Read more
12 Mar 2018 09:43

FTSE 100 lags Europe on miners and energy, Just Eat goes cold

(For a live blog on European stocks, type LIVE/ in an Eikon news window) * FTSE 100 up 0.1 pct * Just Eat hit by DB downgrade * Vectura, Hikma hit by delay to Advair GKN up 12

Read more
16 Feb 2017 07:49

Vectura Hits GBP9 Million Royalty Cap Under Skyepharma Legacy Deal

Read more
16 Feb 2017 07:06

Vectura's GSK royalties agreements firing on all cylinders

(ShareCast News) - Vectura Group hit its royalty cap on sales of GlaxoSmithKline´s Ellipta range of products in 2016, one year ahead of forecasts. The cap was equivalent to £9.0m. The inhaled airways disease-focused business was also set to record £5.4m of 2016 revenues under a separate single digi

Read more
8 Feb 2017 13:49

UPDATE 1-Weak pound buoys GSK but drugmaker warns on 2017 generic threat

* 2017 core EPS seen flat-lower if mid-year generic Advair * Current exchange rates would lift 2017 sterling EPS 9 pct * Q4 2016 core EPS 26.1 pence vs consensus forecast 25.0p (Adds CEO comments, shares, background on new CEO) By Ben Hirschler LONDON, Feb 8 (Reuters) -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.